Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference

b'The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company\xe2\x80\x99s website at www.eagleus.com , under the Investors Section.\nEagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, May 11, 2021
Information
Tags: 
Biotechnology, General Health, Pharmaceutical, Health, XC2, Neagle, Surname, Names
Geotags: 
United States, NEW JERSEY
⚠ generated by AI ↴
Organisation: 
EAGLE PHARMACEUTICALS, INC.
Summary
Key Points: 
  • b'The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company\xe2\x80\x99s website at www.eagleus.com , under the Investors Section.\nEagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise.
  • Eagle is committed to developing innovative medicines that result in meaningful improvements in patients\xe2\x80\x99 lives.
  • Eagle\xe2\x80\x99s commercialized products include RYANODEX\xc2\xae, BENDEKA\xc2\xae, BELRAPZO\xc2\xae, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states.
  • Additional information is available on Eagle\xe2\x80\x99s website at www.eagleus.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210511006203/en/\n'


Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 2021 RBC Capital Markets Global Healthcare Conference as follows:

Date:

Tuesday, May 18, 2021

Time:

1:20 p.m. Eastern Time

Webcast:

https://event.on24.com/wcc/r/3173733/CEA9B803E5C77274A4417D4FE2A0EAB0

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

Copyright: 
Copyright Business Wire 2021